Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Head and Neck Squamous Cell Carcinoma”

182 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 182 results

Early research (Phase 1)Study completedNCT04641871
What this trial is testing

Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies

Who this might be right for
Metastatic CancerSolid Tumor
Symphogen A/S 78
Testing effectiveness (Phase 2)Looking for participantsNCT06122493
What this trial is testing

Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Ruijin Hospital 48
Early research (Phase 1)Study completedNCT00537121
What this trial is testing

Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer

Who this might be right for
Esophageal CancerGastric CancerLiver Cancer
Roswell Park Cancer Institute 23
Large-scale testing (Phase 3)WithdrawnNCT01345084
What this trial is testing

Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab

Who this might be right for
CarcinomaHead and Neck Cancer
Eurofarma Laboratorios S.A.
Testing effectiveness (Phase 2)UnknownNCT05594914
What this trial is testing

AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of University of South China 47
Testing effectiveness (Phase 2)UnknownNCT03817658
What this trial is testing

A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 725
Testing effectiveness (Phase 2)Looking for participantsNCT05086692
What this trial is testing

A Beta-only IL-2 ImmunoTherapY Study

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more
Medicenna Therapeutics, Inc. 115
Not applicableNot Yet RecruitingNCT06756841
What this trial is testing

Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Energenx Medical LTD. 10
Testing effectiveness (Phase 2)Study completedNCT03187314
What this trial is testing

Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal NeoplasmsEsophageal DiseasesEsophageal Squamous Cell Carcinoma
Hangzhou Cancer Hospital 25
Early research (Phase 1)Active Not RecruitingNCT04007744
What this trial is testing

Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+19 more
Mayo Clinic 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04550260
What this trial is testing

Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
AstraZeneca 640
Testing effectiveness (Phase 2)Study completedNCT00623558
What this trial is testing

Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)

Who this might be right for
Head and Neck Neoplasm
Seoul National University Hospital 92
Early research (Phase 1)Study completedNCT00397384
What this trial is testing

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more
National Cancer Institute (NCI) 43
Early research (Phase 1)Ended earlyNCT04465487
What this trial is testing

Study of REGN6569 and Cemiplimab in Adult Patients With Advanced Solid Tumor Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Regeneron Pharmaceuticals 38
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07062354
What this trial is testing

Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head &Amp; Neck CancerHead &Amp; Neck Squamous Cell Carcinoma
SWOG Cancer Research Network 50
Testing effectiveness (Phase 2)Looking for participantsNCT07530094
What this trial is testing

Short-Course Definitive Chemoradiotherapy Combined With Adjuvant or Concurrent Plus Adjuvant Camrelizumab for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Ning Jiang, M.D./Ph.D. 98
Testing effectiveness (Phase 2)WithdrawnNCT03114280
What this trial is testing

Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Centre Antoine Lacassagne
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Early research (Phase 1)Ended earlyNCT02438995
What this trial is testing

Super-Selective Intraarterial Infusion of Cetuximab (Erbitux) With or Without Radiation Therapy for the Treatment of Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Carcinoma, Squamous CellCarcinoma, Squamous Cell of Head and Neck
Northwell Health 11
Not applicableLooking for participantsNCT05047094
What this trial is testing

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaSkin CancerMetastatic Head-and-neck Squamous-cell Carcinoma
Alpha Tau Medical LTD. 48
Load More Results